aiwiki.page
English
Health / Medicine & Treatment / hyper-igm-syndrome

Hyper-IgM Syndrome

Hyper-IgM syndrome comprises inherited immune disorders characterized by impaired antibody class switching, low IgG and IgA, and normal or elevated IgM.

20 keywords1 linked from2 not yet writtenWritten by AI
Inborn Errors of…AntibodyB CellClass-Switch Rec…T CellImmunodeficiencyOpportunistic In…Otitis mediaHyper-IgM…

Hyper-IgM syndrome is a group of inborn errors of immunity in which the immune system cannot effectively produce certain classes of antibodies. The characteristic laboratory pattern is markedly reduced immunoglobulin G (IgG) and immunoglobulin A (IgA), often with reduced immunoglobulin E (IgE), while immunoglobulin M (IgM) is normal or elevated. Affected individuals have increased susceptibility to infections, but the clinical pattern depends on the underlying genetic defect. Despite its name, the syndrome does not require an elevated IgM concentration.

Biological basis

Antibodies are produced by B lymphocytes, or B cells. During a normal immune response, activated B cells can change the class of antibody they produce through class-switch recombination. This process changes an antibody’s constant region, allowing it to perform different immune functions while retaining its original antigen specificity.

Class switching depends on several coordinated processes:

  • Communication between activated T cells and B cells, particularly through the interaction of CD40 ligand on T cells with CD40 on B cells.
  • Signals that direct the production of particular antibody classes.
  • Enzymes and DNA-repair mechanisms that rearrange antibody genes.

Defects in these processes can leave B cells able to produce IgM but unable to produce adequate amounts of other antibody classes. Total circulating B-cell numbers are often preserved; the disorder is therefore not simply an absence of B cells.

The affected pathway also determines whether the condition is predominantly an antibody deficiency or a broader immunodeficiency. CD40 ligand and CD40 participate in immune functions beyond antibody production, including activation of cells involved in controlling intracellular pathogens. Their deficiency can therefore cause substantial susceptibility to opportunistic infections.

Genetic forms and inheritance

“Hyper-IgM syndrome” describes a shared immunological pattern rather than one genetically uniform disease. Gene-based terminology is more precise than older numbered classifications.

Genetic defect Typical inheritance Principal features
CD40 ligand deficiency, caused by pathogenic variants in CD40LG X-linked Impaired T-cell–B-cell communication, defective class switching, and susceptibility to bacterial and opportunistic infections
CD40 deficiency, caused by pathogenic variants in CD40 Autosomal recessive A combined immune defect resembling CD40 ligand deficiency
Activation-induced cytidine deaminase deficiency, caused by pathogenic variants in AICDA Usually autosomal recessive Predominantly impaired antibody class switching, often with enlarged lymphoid tissues
Uracil-DNA glycosylase deficiency, caused by pathogenic variants in UNG Autosomal recessive Defective processing of DNA changes required for class switching

CD40 ligand deficiency is the most common and best-characterized form. Because CD40LG is located on the X chromosome, it predominantly affects males. Females carrying a pathogenic variant are generally unaffected, although clinical expression can occasionally occur.

Other genetic disorders affecting immune signaling or DNA repair can produce a hyper-IgM-like laboratory pattern. Some have additional developmental or nonimmune features. Consequently, an antibody profile alone does not establish a specific genetic diagnosis.

Clinical manifestations

Recurrent infections

Symptoms often begin in infancy or early childhood. Recurrent infections of the ears, sinuses, and lungs are common, including otitis media and pneumonia. Repeated lower respiratory infections may cause chronic structural lung damage.

In CD40 ligand or CD40 deficiency, Pneumocystis jirovecii pneumonia may be an early presentation. Persistent or recurrent diarrhea can result from intestinal infections, including infection with Cryptosporidium. These opportunistic infections are much less characteristic of defects confined mainly to antibody class switching, such as typical AICDA deficiency.

Blood and lymphoid abnormalities

Neutropenia is a recognized feature, particularly in CD40 ligand deficiency. It can be intermittent or persistent and may accompany oral ulcers or bacterial infections.

Enlargement of lymph nodes and tonsils is especially characteristic of activation-induced cytidine deaminase deficiency. This reflects abnormal lymphoid responses rather than effective production of class-switched antibodies.

Liver disease and immune dysregulation

Chronic Cryptosporidium infection can involve the biliary tract and is associated with sclerosing cholangitis, a progressive inflammatory and scarring disease of the bile ducts. Advanced liver disease is an important complication of CD40 ligand deficiency.

Autoimmunity and inflammatory complications can also occur. Their frequency and form vary with the molecular defect. Certain forms have an increased risk of malignancy, including lymphoma, although this risk is not uniform across all hyper-IgM disorders.

Diagnosis

Diagnosis combines clinical findings, immunological testing, and molecular genetic analysis. The characteristic findings include low IgG and IgA concentrations with normal or elevated IgM, interpreted against age-specific reference ranges.

Investigations may include:

  • Quantitative measurements of serum immunoglobulins.
  • Assessment of antibody responses to previous immunization or infection.
  • Lymphocyte counts and B-cell subset analysis, including class-switched memory B cells.
  • Measurement of CD40 ligand expression on activated T cells or CD40 expression on relevant cells.
  • Genetic testing to identify the underlying defect.

Normal expression of CD40 ligand does not exclude a functionally abnormal protein. Molecular testing can distinguish conditions that have similar antibody profiles but different infection risks and treatment implications.

The differential diagnosis includes common variable immunodeficiency, other inherited antibody deficiencies, and secondary causes of low immunoglobulin concentrations. An isolated high IgM level is not sufficient for diagnosis; elevated IgM can also occur in infections, liver disease, and other unrelated conditions.

Treatment and clinical course

Treatment is directed at the specific genetic disorder and its complications. Immunoglobulin replacement therapy supplies IgG antibodies and reduces susceptibility to many bacterial infections. It does not fully correct the cellular immune abnormalities associated with CD40 ligand or CD40 deficiency.

Clinical care may also include antimicrobial prophylaxis, treatment of established infections, and management of neutropenia or organ complications. Prophylaxis against Pneumocystis jirovecii is an established component of care for CD40 ligand deficiency. Vaccination practices depend on the type and severity of the immune defect; live attenuated vaccines can pose risks in forms with significant combined immune dysfunction.

Hematopoietic stem cell transplantation can provide definitive treatment for CD40 ligand deficiency and some other severe forms by replacing defective blood-forming and immune cells. Outcomes depend on factors including pre-existing infections, organ damage, donor characteristics, and transplantation procedures. Transplantation is not routinely used for every disorder producing a hyper-IgM phenotype.

Prognosis varies substantially by genotype and by the presence of chronic lung or liver disease. Predominantly B-cell-intrinsic forms generally have a different clinical course from CD40 ligand and CD40 deficiencies, in which opportunistic infections and biliary complications are major concerns.

Epidemiology and family implications

Hyper-IgM syndromes are rare, and precise population frequencies are difficult to establish because of their genetic diversity and incomplete recognition. The absence of a family history does not exclude the diagnosis.

Once a disease-causing variant has been identified, family testing can clarify carrier status and identify affected relatives. Genetic counseling addresses the specific inheritance pattern, recurrence risks, and available reproductive testing options.